A unique preliminary study on placental apoptosis in mice with passive immunization of anti-phosphatidylethanolamine antibodies and anti-factor XII antibodies

American Journal of Reproductive Immunology

Volumn 66, Issue 5, 2011, Pages 373-384

  Velayuthaprabhu, Shanmugam ^a,b   Matsubayashi, Hidehiko ^b,c   Sugi, Toshitaka ^b,d   Nakamura, Masato ^b,e   Ohnishi, Yasuyuki ^e   Ogura, Tomoyuki ^e   Tomiyama, Tatsuhiro ^c   Archunan, Govindaraju ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Osaka New ART Clinic   (Japan)

^d Sugi Women's Clinic   (Japan)

^e CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

aFXII; APE; APS; Placental apoptosis; Pregnancy loss

Indexed keywords

ASPARTIC ACID; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 12 ANTIBODY; CYSTEINE; IMMUNOGLOBULIN; ISOLEUCINE; LEUCINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE ANTIBODY; POLYCLONAL ANTIBODY; PROLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLEEDING; CELL INVASION; CONTROLLED STUDY; DECIDUA; DISEASE ASSOCIATION; FEMALE; FETUS RESORPTION; GIANT CELL; HUMAN; MALE; MITOSIS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLACENTA DISORDER; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOSIS; TROPHOBLAST;

ABORTION, INDUCED; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; APOPTOSIS; FACTOR XII; FEMALE; FETAL RESORPTION; HUMANS; IMMUNIZATION, PASSIVE; MALE; MICE; MICE, INBRED ICR; PHOSPHATIDYLETHANOLAMINES; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; THROMBOSIS;

EID: 80054032533     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01008.x     Document Type: Article

References (55)

1. McIntyre JA, Wagenknecht DR, Faulk WP: Antiphospholipid antibodies: discovery, definitions, detection and disease. Prog Lipid Res 2003; 42:176-237.
2. Yetman DL, Kutteh WH: Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996; 66:540-546.
3. Branch DW, Silver R, Pierangeli S, Van Leeuwen I, Harris EN: Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls and antiphospholipid syndrome. Obstet Gynecol 1997; 89:549-555.
4. Matsubayashi H, Sugi T, Arai T, Kondo A, Suzuki T, Izumi S, McIntyre JA, Makino T: Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am J Reprod Immunol 2001; 46:323-329.
5. Gris JC, Ripart-Neveu S, Maugard C, Tailland ML, Brun S, Courtieu C, Biron C, Hoffet M, Hédon B, Marès P: Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thromb Haemost 1997; 77:1096-1103.
6. Gris JC, Quere I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert AM, Ripart-Neveu S, Hoffet M, Tailland ML, Rousseau O, Monpeyroux F, Dauzat M, Sampol J, Daures JP, Berlan J, Marès P: Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study - NOHA. Thromb Haemost 2000; 84:228-236.
7. Reproduction and Endocrinology Committee Report: Incidence of the causes for patients with recurrent pregnancy loss. Acta Obst Gynaec Jpn 2005; 57:1057-1058 (in Japanese).
8. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
9. Stern C, Chamley L, Hale L, Kloss M, Speirs A, Baker HW: Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertil Steril 1998; 70:938-944.
10. Vinatier D, Dufour P, Cosson M, Houpeau JL: Antiphospholipid syndrome and recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 2001; 96:37-50.
11. Boffa MC, Berard M, Sugi T, McIntyre JA: Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity. J Rheumatol 1996; 23:1375-1379.
12. Balada E, Ordi-Ros J, Paredes F, Villarreal J, Mauri M, Vilardell-Tarres M: Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. Scand J Rheumatol 2001; 30:235-241.
13. Sugi T, McIntyre JA: Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995; 86:3083-3089.
14. Sugi T, Mclntyre JA: Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies. Thromb Haemost 1996; 76:354-360.
15. Katsunuma J, Sugi T, Inomo A, Matsubayashi H, Izumi S, Makino T: Kininogen domain 3 contains regions recognized by antiphosphatidylethanolamine antibodies. J Thromb Haemost 2003; 1:132-138.
16. Sugi T, Makino T: Autoantibodies to contact proteins in patients with recurrent pregnancy losses. J Reprod Immunol 2002; 53:269-277.
17. Sugi T, Makino T: Factor XII, kininogen and plasma prekallikrein in abnormal pregnancies. Curr Drug Targets 2005; 6:551-557.
18. Jones DW, MacKie IJ, Gallimore MJ, Winter M: Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome. Br J Haematol 2001; 113:550-552.
19. Inomo A, Sugi T, Fujita Y, Matsubayashi H, Izumi S, Mikami M: The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses. Thromb Haemost 2008; 99:316-323.
20. Pauer HU, Renné T, Hemmerlein B, Legler T, Fritzlar S, Adham I, Müller-Esterl W, Emons G, Sancken U, Engel W, Burfeind P: Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo. Thromb Haemost 2004; 92:503-508.
21. Iwaki T, Castellino FJ: Plasma levels of bradykinin are suppressed in factor XII-deficient mice. Thromb Haemost 2006; 95:1003-1010.
22. Sugi T: EBM Management of Recurrent Pregnancy Losses: Basic Principles and Clinical Practice. Practice for Patients with Recurrent Pregnancy Loss Based on EBM. Tokyo, Kanehara Syuppann, 2007 (in Japanese).
23. Wada H, Nishioka J, Kasai Y, Kato-Nakazawa K, Abe Y, Morishita Y, Nakatani K, Nobori T: Molecular characterization of coagulation factor XII deficiency in a Japanese family. Thromb Haemost 2003; 90:59-63.
24. Glucksmann A: Cell deaths in normal vertebrate ontogeny. Biol Rev 1951; 26:59-86.
25. Sharp AN, Heazell AEP, Crocker IP, Mor G: Placental apoptosis in health and diseases. Am J Reprod Immunol 2010; 63:159-169.
26. Straszewski-Chavez SL, Abrahams VM, Mor G: The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev 2005; 26:877-897.
27. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991; 88:3069-3073.
28. Blank M, Tincani A, Shoenfeld Y: Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol 1994; 21:100-104.
29. George J, Blank M, Levy Y, Meroni P, Damianovich M, Tincani A, Shoenfeld Y: Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998; 97:900-906.
30. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y: Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89:1558-1563.
31. Blank M, Faden D, Tincani A, Kopolovic J, Goldberg I, Gilburd B, Allegri F, Balestrieri G, Valesini G, Shoenfeld Y: Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7:441-455.
32. Velayuthaprabhu S, Archunan G, Balakrishnan K: Placental thrombosis in experimental anticardiolipin antibodies-mediated intrauterine fetal death. Am J Reprod Immunol 2007; 57:270-276.
33. Bose P, Black S, Kadyrov M, Bartz C, Shlebak A, Regan L, Huppertz B: Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol 2004; 191:2125-2131.
34. Yacobi S, Ornoy A, Blumenfeld Z, Miller RK: Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 2002; 66:300-308.
35. Ornoy A, Yacobi S, Matalon ST, Blank M, Blumenfeld Z, Miller RK, Shoenfeld Y: The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus 2003; 12:573-578.
36. Schwartz N, Shoenfeld Y, Barzilai O, Cervera R, Font J, Blank M, Yacobi S, Patlas N, Cohen A, Mevorach D, Ornoy A: Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS. Lupus 2007; 16:110-120.
37. Sugi T, Matsubayashi H, Inomo A, Dan L, Makino T: Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to late pregnancy loss. J Obstet Gynaecol Res 2004; 30:326-332.
38. Mizugishi K, Li C, Olivera A, Bielawski J, Bielawska A, Deng CX, Proia RL: Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice. J Clin Invest 2007; 117:2993-3006.
39. Tian Y, Jackson P, Gunter C, Wang J, Rock CO, Jackowski S: Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2. J Biol Chem 2006; 281:28438-28449.
40. Di Simone N, Castellani R, Raschi E, Borghi MO, Meroni PL, Caruso A: Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. Ann N Y Acad Sci 2006; 1069:364-376.
41. Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sie P, Boffa MC: Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Thromb Haemost 2007; 97:949-954.
42. Reddigari SR, Shibayama Y, Brunnee T, Kaplan AP: Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells. J Biol Chem 1993; 268:11982-11987.
43. Bradford HN, Pixley RA, Colman RW: Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem 2000; 275:22756-22763.
44. Bradford HN, Dela Cadena RA, Kunapuli SP, Dong JF, Lopez JA, Colman RW: Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex. Blood 1997; 90:1508-1515.
45. Herwald H, Hasan AA, Godovac-Zimmermann J, Schmaier AH, Müller-Esterl W: Identification of an endothelial cell binding site on kininogen domain D3. J Biol Chem 1995; 270:14634-14642.
46. Clarke BJ, Cote HC, Cool DE, Clark-Lewis I, Saito H, Pixley RA, Colman RW, MacGillivray RT: Mapping of a putative surface-binding site of human coagulation factor XII. J Biol Chem 1989; 264:11497-11502.
47. Smith SC, Baker PN, Symonds EM: Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997; 177:1395-1401.
48. Crocker IP, Cooper S, Ong SC, Baker PN: Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003; 162:637-643.
49. Kokawa K, Shikone T, Nakano R: Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta 1998; 19:21-26.
50. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, Thaler HT, Romero R: Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187:1137-1142.
51. Mu J, Kanzaki T, Tomimatsu T, Fukuda H, Wasada K, Fuji E, Endoli M, Kozuki M, Murata Y, Sugimoto Y, Ichikawa A: Expression of apoptosis in placentae from mice lacking the prostaglandin F receptor. Placenta 2002; 23:215-223.
52. Rauch J, Subang R, D'Agnillo P, Koh JS, Levine JS: Apoptosis and the antiphospholipid syndrome. J Autoimmun 2000; 15:231-235.
53. Di SimoneN, Luigi MP, Marco D, Fiorella DN, Silvia D, Clara DM, Alessandro C: Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies: a review of the literature. Ann N Y Acad Sci 2007; 1108:505-514.
54. Linzer DI, Fisher SJ: The placenta and the prolactin family of hormones: regulation of the physiology of pregnancy. Mol Endocrinol 1999; 13:837-840.
55. Soares MJ: The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface. Reprod Biol Endocrinol 2004; 2:1-15.